Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00543933 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Study of Inhaled Nitric Oxide to Treat Pulmonary Insufficiency in Congenital Heart Disease
A Early Phase 1 study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 18
- Enrollment target
NCT00543933: Clinical Trial Early Phase 1 study, sponsored by The Cleveland Clinic.
NCT00543933 is a Early Phase 1 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 18 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00543933, a Early Phase 1 study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
Inhaled nitric oxide in patients with pulmonic valve insufficiency.
Primary Outcome
Aortic regurgitant fraction measured by CMR velocity flow mapping
Interventions
- DRUG iNO administered
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-06 |
| Phase | Early Phase 1 |
Why NCT00543933 stopped before completion
NCT00543933 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 1 intervention - of which iNO administered is the first listed.
NCT00543933 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00543933 about?
NCT00543933 is a clinical study titled "Pilot Study of Inhaled Nitric Oxide to Treat Pulmonary Insufficiency in Congenital Heart Disease". Inhaled nitric oxide in patients with pulmonic valve insufficiency.
What is the current status of trial NCT00543933?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 18 participants. The study started on 2007-10. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00543933?
The interventions under investigation include: iNO administered (DRUG).
Who is sponsoring clinical trial NCT00543933?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00543933's enrollment target sits among peer trials
18 1316th of 2000 higher than 651 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia